We rank companies based on fund manager, research analyst and news sentiment
HCAT stock icon

Health Catalyst, Inc Common Stock
HCAT

$6.09
1.13%
 

About: Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Employees: 1,300

0
Funds holding %
of 6,474 funds
0
Analysts bullish %
of 13 analysts
0
News positive %
of 3 articles

Fund manager confidence

Based on 2023 Q4 SEC filings by fund managers ($100M+ AUM)

700% more call options, than puts

Call options by funds: $51.9K | Put options by funds: $6.48K

30% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 23

4% more funds holding

Funds holding: 157 [Q3] → 164 (+7) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 2 [Q3] → 2 (+0) [Q4]

0.2% less ownership

Funds ownership: 86.6% [Q3] → 86.4% (-0.2%) [Q4]

8% less capital invested

Capital invested by funds: $499M [Q3] → $460M (-$39.5M) [Q4]

12% less repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 59

Research analyst outlook

13 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$8
31%
upside
Avg. target
$12.08
98%
upside
High target
$16
163%
upside

13 analyst ratings

11 positive
85%
neutral
15%
negative
0%
Cantor Fitzgerald
Sarah James
163%upside
$16
Overweight
Reiterated
10 Apr 2024
Cantor Fitzgerald
Sarah James
163%upside
$16
Overweight
Reiterated
5 Mar 2024
Keybanc
Scott Schoenhaus
64%upside
$10
Overweight
Maintained
26 Feb 2024
Piper Sandler
Jessica Tassan
146%upside
$15
Overweight
Reiterated
23 Feb 2024
Evercore ISI Group
Elizabeth Anderson
64%upside
$10
Outperform
Maintained
23 Feb 2024

Financial journalist opinion

Based on 3 articles about HCAT published over the past 30 days